EA200400177A1 - Способ получения эсциталопрама - Google Patents

Способ получения эсциталопрама

Info

Publication number
EA200400177A1
EA200400177A1 EA200400177A EA200400177A EA200400177A1 EA 200400177 A1 EA200400177 A1 EA 200400177A1 EA 200400177 A EA200400177 A EA 200400177A EA 200400177 A EA200400177 A EA 200400177A EA 200400177 A1 EA200400177 A1 EA 200400177A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining
escitaloprama
escitalopram
presented
citalopram
Prior art date
Application number
EA200400177A
Other languages
English (en)
Other versions
EA014823B1 (ru
Inventor
Микаэль Бек Соммер
Оле Нильсен
Ханс Петерсен
Халех Ахмадиан
Хенрик Педерсен
Петер Бресен
Фиона Гайзер
Джеймс Ли
Джеффри Кокс
Оливье Дапремон
Кристина Сюте
Себастьян П. Ассенза
Шанкар Харихаран
Уша Наир
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200400177(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200400177A1 publication Critical patent/EA200400177A1/ru
Publication of EA014823B1 publication Critical patent/EA014823B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Представлен новый способ получения эсциталопрама. Способ включает хроматографическое разделение энантиомеров циталопрама или промежуточного соединения для получения циталопрама с применением хиральной неподвижной фазы, такой как Chiralpak™ AD или Chiralcel™ OD. Также представлены новые хиральные промежуточные соединения для синтеза эсциталопрама, полученные указанным способом.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400177A 2001-07-13 2002-07-12 Способ получения эсциталопрама EA014823B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200101101 2001-07-13
DKPA200101851 2001-12-11
DKPA200101852 2001-12-11
PCT/DK2002/000491 WO2003006449A1 (en) 2001-07-13 2002-07-12 Method for the preparation of escitalopram

Publications (2)

Publication Number Publication Date
EA200400177A1 true EA200400177A1 (ru) 2004-06-24
EA014823B1 EA014823B1 (ru) 2011-02-28

Family

ID=27222518

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400177A EA014823B1 (ru) 2001-07-13 2002-07-12 Способ получения эсциталопрама

Country Status (29)

Country Link
US (2) US20050065207A1 (ru)
EP (1) EP1409472A1 (ru)
JP (1) JP2004538276A (ru)
KR (4) KR20080108628A (ru)
CN (2) CN101265199A (ru)
AR (1) AR034759A1 (ru)
AU (1) AU2009200448A1 (ru)
BG (1) BG108572A (ru)
BR (1) BR0210817A (ru)
CA (1) CA2451124C (ru)
CO (1) CO5550496A2 (ru)
EA (1) EA014823B1 (ru)
HK (1) HK1069386A1 (ru)
HR (1) HRPK20031074B3 (ru)
HU (1) HUP0401451A3 (ru)
IL (1) IL159183A0 (ru)
IS (1) IS7064A (ru)
ME (1) MEP2008A (ru)
MX (1) MXPA04000205A (ru)
MY (1) MY144333A (ru)
NO (1) NO328561B1 (ru)
PE (1) PE20030253A1 (ru)
PL (1) PL366383A1 (ru)
RS (1) RS1804A (ru)
TW (1) TWI268926B (ru)
UA (1) UA84258C2 (ru)
UY (1) UY27379A1 (ru)
WO (1) WO2003006449A1 (ru)
ZA (1) ZA200309471B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
EP1581483B1 (en) 2002-12-23 2012-06-06 H. Lundbeck A/S A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
ES2228274B1 (es) * 2003-09-24 2006-06-01 Astur Pharma, S.A. Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
ITMI20041872A1 (it) * 2004-10-01 2005-01-01 Adorkem Technology Spa Processo per la preparazione di citalopram e di scitalopram
EP1877394A1 (en) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Process for the preparation of escitalopram or its acid addition salts
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CA2625835A1 (en) 2005-10-14 2007-05-10 Forest Laboratories, Inc. Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
CN101309924A (zh) * 2005-11-14 2008-11-19 H.隆德贝克有限公司 依地普仑的制备方法
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
EP1988086B2 (en) 2007-04-23 2014-11-26 Synthon B.V. Process for resolving citalopram via its (S)-enriched citalopram tartrate compound.
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
US8022232B2 (en) 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
FI121570B (fi) 2007-09-11 2011-01-14 Lundbeck & Co As H Menetelmä essitalopraamin valmistamiseksi
CN106568863A (zh) * 2016-11-04 2017-04-19 北京万全德众医药生物技术有限公司 一种用高效液相色谱法分离测定草酸艾司西肽普兰中间体光学异构体的方法
CN107941962A (zh) * 2017-12-28 2018-04-20 北京和合医学诊断技术股份有限公司 检测血液中艾司西酞普兰药物含量的液相色谱分析方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JP3010816B2 (ja) 1991-08-22 2000-02-21 ダイセル化学工業株式会社 光学分割における光学異性体と溶媒との回収方法、溶媒の循環使用方法、および光学異性体の再利用方法
US5514818A (en) * 1993-09-17 1996-05-07 Daicel Chemical Industries, Ltd. Resolution of stereoisomers of aliphatic epoxides
US5889180A (en) * 1997-11-10 1999-03-30 Uop Llc Use of small pore silicas as a support for a chiral stationary phase
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
US6764200B1 (en) * 2003-01-15 2004-07-20 Hsiang Lan Wu Liu Decorative lantern

Also Published As

Publication number Publication date
KR20100036387A (ko) 2010-04-07
NO328561B1 (no) 2010-03-22
KR20080108629A (ko) 2008-12-15
US20110065938A1 (en) 2011-03-17
HUP0401451A3 (en) 2007-05-29
AR034759A1 (es) 2004-03-17
KR100956260B1 (ko) 2010-05-07
BG108572A (bg) 2005-03-31
RS1804A (en) 2006-12-15
CA2451124C (en) 2009-11-24
UA84258C2 (en) 2008-10-10
PL366383A1 (en) 2005-01-24
NO20040027L (no) 2004-01-05
US20050065207A1 (en) 2005-03-24
CN101265199A (zh) 2008-09-17
WO2003006449A1 (en) 2003-01-23
EP1409472A1 (en) 2004-04-21
MEP2008A (xx) 2010-02-10
HRPK20031074B3 (en) 2009-10-31
JP2004538276A (ja) 2004-12-24
MY144333A (en) 2011-08-29
BR0210817A (pt) 2004-06-22
MXPA04000205A (es) 2004-03-18
HRP20031074A2 (en) 2004-04-30
PE20030253A1 (es) 2003-03-19
CO5550496A2 (es) 2005-08-31
EA014823B1 (ru) 2011-02-28
UY27379A1 (es) 2003-02-28
IS7064A (is) 2003-12-04
HK1069386A1 (en) 2005-05-20
CA2451124A1 (en) 2003-01-23
TWI268926B (en) 2006-12-21
AU2009200448A1 (en) 2009-03-05
CN1527825A (zh) 2004-09-08
ZA200309471B (en) 2004-12-06
KR20080108628A (ko) 2008-12-15
IL159183A0 (en) 2004-06-01
HUP0401451A2 (hu) 2004-11-29
CN100457746C (zh) 2009-02-04
KR20040030046A (ko) 2004-04-08

Similar Documents

Publication Publication Date Title
EA200400177A1 (ru) Способ получения эсциталопрама
EA200400809A1 (ru) Способ получения эсциталопрама
ATE469877T1 (de) Verfahren zur dehydratisierung substituierter 4- dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-aryl-butyl)-amin-verbindungen mittels heterogener katalyse
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
EA200401551A1 (ru) Получение сульфинилацетамида
EA200300279A1 (ru) Способ получения циталопрама
EA199800302A1 (ru) Способ получения дифторметана
PE20100234A1 (es) Nuevo procedimiento de resolucion de enantiomeros de (3,4-dimetoxi-biciclo[4.2.0]octa-1,3,5-trien-7-il)nitrilo y aplicacion en la sintesis de ivabradina
EA200200355A1 (ru) Тиеноизоксазолил- и тиенилпирразолилфеноксизамещенные пролилпроизводные, используемые в качестве антагонистов рецептора d
EA200500349A1 (ru) Способ выделения промежуточных соединений, которые могут использоваться для получения эсциталопрама
EA200200969A1 (ru) Способ получения циталопрама
DK1246813T3 (da) Fremgangsmåde til fremstilling af Citalopram
Kamal et al. Chemoenzymatic synthesis of (S) and (R)-propranolol and sotalol employing one-pot lipase resolution protocol
EA200201211A1 (ru) Способ получения циталопрама
EA200200356A1 (ru) Бензизоксазолил-, пиридоизоксазолил- и бензтиенилфеноксипроизводные, используемые в качестве антагонистов рецептора d4
EA200100040A1 (ru) Химический синтез морфолиновых производных
EA199900772A1 (ru) Способ селективного эпоксидирования для получения лекарственных соединений
EA199900740A1 (ru) Способ получения эпросартана (варианты)
EA200400876A1 (ru) Способ получения производных толуола
DK1673365T3 (da) Fremgangsmåde til fremstillingen af Z-flupentixol
EA200200162A1 (ru) Способ деацилирования липодепсипептидов
Beneke et al. α-Carboxy-β-Lactones from Photoinduced Ring Contraction of 3-Diazodihydrofuran-2, 4-diones
AR037046A1 (es) Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida
DK0934256T3 (da) Fremgangsmåde til fremstilling af cyanocinnamamider
DK1082449T3 (da) Fremgangsmåder til stereoselektiv fremstilling af substituerede cyclohexylcyanhydriner

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY